Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CNC
#471
Centene Corporation
44.7
7
+5.64%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+5.64%
Changement Mensuel
+8.38%
Evolution sur 6 mois
+54.86%
Changement Annuel
-22.78%
Clôture Précédente
42.3
8
Open
44.1
2
Bid
Ask
Low
44.1
2
High
44.8
0
Volume
2 383
Marchés
Actions des Marchés US
Soins de Santé
CNC
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Total assets
82.35 B
82.44 B
87.04 B
86.39 B
82.09 B
76.75 B
Total liabilities
54.94 B
55.94 B
59.02 B
58.89 B
61.03 B
56.69 B
Total equity
27.4 B
26.5 B
28.01 B
27.49 B
21.03 B
20.03 B
Total liabilities & shareholders' equities
82.35 B
82.44 B
87.04 B
86.39 B
82.09 B
76.75 B
Total debt
—
—
—
—
—
—
Net debt
—
—
—
—
—
—
Centene Corporation
Centene Corporation is an American for-profit healthcare company that serves as an intermediary for government-sponsored and privately insured healthcare programs. Based in Clayton, Missouri, Centene ranked No. 23 on the 2025 Fortune 500.
Nouvelles
Clover Health earnings on deck as insurer eyes profitability turn
Truist eleva el precio objetivo de Centene por oportunidades de margen
Truist eleva precio objetivo de Centene por oportunidades en márgenes
Truist raises Centene stock price target on margin opportunities
UnitedHealthcare Under Pressure: Can UNH's Core Business Rebound?
Wells Fargo rebaja calificación de Molina Healthcare por preocupaciones
Why Centene (CNC) is a Top Value Stock for the Long-Term
Republican-led US House panel issues subpoenas to eight health insurers, Axios reports
Truist Securities reitera calificación de Compra para Centene con objetivo de $47
Truist Securities reiterates Buy rating on Centene stock with $47 target
Cantor Fitzgerald maintains Neutral rating on Centene stock amid challenging outlook
Centene: Aggressive Re-Pricing/Cut Deliver Improved Margin Of Safety - Reiterate Buy (CNC)